ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE (COMBINATION VS SEQUENTIAL TREATMENT) FOR HIGH-RISK MYELODYSPLASTIC SYNDROMES (IPSS RISK: HIGH OR INT-2): A PHASE II CLINICAL AND BIOLOGICAL STUDY